U-Blot® Research Grade PuxitatugCat. No. WA3400Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade PuxitatugCat. No. WA3400
U-Blot® Research Grade pumitamigCat. No. WA3399
U-Blot® Research Grade PulocimabCat. No. WA3398
U-Blot® Research Grade PucotenlimabCat. No. WA3397
U-Blot® Research Grade ProlgolimabCat. No. WA3396
U-Blot® Research Grade produvofuspCat. No. WA3395
U-Blot® Research Grade PritumumabCat. No. WA3394
U-Blot® Research Grade PritoxaximabCat. No. WA3393
U-Blot® Research Grade PriliximabCat. No. WA3392
U-Blot® Research Grade PrezalumabCat. No. WA3391
U-Blot® Research Grade PrecemtabartCat. No. WA3390
U-Blot® Research Grade PrasinezumabCat. No. WA3389